• Mashup Score: 0
    Safety and Disease Related Outcomes of mCRPC Patients Who Were Treated with Radium-223 Then 177Lu-PSMA (RALU) - Neal Shore - 10 month(s) ago

    Neal Shores joins Alicia Morgans in conversation to discuss the RALU study. RALU is a retrospective analysis that sought to evaluate the safety and clinical outcomes of sequential radium-223/177Lu-PSMA therapy in patients with metastatic castration-resistant prostate cancer (mCRPC). The study found that patients tolerated Lutetium-177 well, and PSA and alkaline phosphatase declines were…

    Source: UroToday
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Safety and disease-related outcomes of #mCRPC patients treated with radium-223 then 177Lu-PSMA in the #RALU study. Join Neal Shore, MD, FACS @AtlanticUrology and @CaPsurvivorship @DanaFarber as they discuss these results on UroToday > https://t.co/XJS9XTt2jh @Bayer https://t.co/hC04gFU5Th

  • Mashup Score: 2
    Merit-Based Incentive Payment System Quality Reporting in Urology Practices - Avinash Maganty - 10 month(s) ago

    Avinash Maganty discusses his published article on the Merit-Based Incentive Payment System (MIPS). MIPS, an initiative launched as part of the MACRA initiative, has revolutionized the way Medicare reimburses physicians. While aiming to align quality with physician reimbursement, the system requires physicians to measure performance across four categories. However, its impact on specialists,…

    Source: UroToday
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Merit-based incentive payment system quality reporting in #Urology practices. Avinash Maganty @UMichUrology and @RuchikaTalwarMD @VUMCurology discuss concerns about the MIPS system's relevance and effectiveness in urological care > https://t.co/bqai1l8Y4S https://t.co/6beIQsmKeG

  • Mashup Score: 2
    Navigating Catheter Selection, Insurance Coverage, and Reimbursement - Diane Newman & Don Darais - 10 month(s) ago

    In this discussion, Diane Newman, a Urologic Nurse Practitioner and Don Darais, the Associate Director of US Marketing for ConvaTec, explore the complexities of catheter selection, reimbursement, and insurance coverages. Newman emphasizes the importance of individualized patient care in choosing the right catheter, highlighting the need for medical necessity letters for specific products….

    Source: UroToday
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      #WatchNow Navigating the intricate world of #catheter selection, #insurance coverage, and patient-centered care with @DrDianeNewman @PennUrology and Don Darais @Convatec. Empowering choices through partnership! #CatheterCare > https://t.co/tSjuGlyKzS https://t.co/hYtoda3xDP

  • Mashup Score: 1
    Can a Catheter Tip Improve a Difficult Intermittent Catheterization? Curved Tip Catheters - Diane Newman - 10 month(s) ago

    Multiple intermittent catheterization attempts can cause anxiety, stress, and can traumatize the urethra. Diane Newman discusses the importance of understanding the benefits of the catheter tip to eliminate difficulty with inserting a catheter for intermittent catheterization. Polished, smooth eyelets may decrease urethral trauma from repeated catheterizations. Biographies: Diane K. Newman, DNP…

    Source: UroToday
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Can a catheter tip improve a difficult intermittent catheterization? Curved tip catheters. #WatchNow @DrDianeNewman @PennUrology on the benefits of the catheter tip to eliminate difficulty with inserting a #catheter for intermittent catheterization > https://t.co/ZjFzNYTrQ1 https://t.co/cgClfXDRog

  • Mashup Score: 0
    Long-Term Follow-up from the JAVELIN Bladder 100 Trial - Srikala Sridhar - 10 month(s) ago

    Srikala Sridhar joins Sam Chang in discussing long-term follow-up from the JAVELIN Bladder 100 trial of avelumab first-line maintenance for advanced urothelial carcinoma. The JAVELIN-100 study was conducted on patients with metastatic urothelial carcinoma who had received frontline platinum-based chemotherapy and achieved a disease response. These patients were then randomized to receive either…

    Source: UroToday
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Long-term follow-up from the #JAVELIN Bladder 100 Trial. @kalasri3 @pmcancercentre joins @UroCancerMD @VUMCurology to discuss these results on UroToday > https://t.co/zaCwLPbslk @EMDSerono https://t.co/W5ucTuExmf

  • Mashup Score: 0
    The Relationship Between a Priori Defined Prognostic Risk Groups and Overall Survival in Men with mHSPC - Susan Halabi - 10 month(s) ago

    Andrea Miyahira and Susan Halabi discuss Dr Halabi’s prognostic model for overall survival in patients with metastatic castration-resistant prostate cancer. Originating in the early 2000s, the model sought to provide patients with more specific information about their prognoses and categorize them into different risk groups. Dr. Halabi’s model comprises eight easily obtainable clinical…

    Source: UroToday
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Discover the relationship between a priori-defined prognostic risk groups and overall survival in men with #mHSPC. Susan Halabi, PhD @DukeCancer joins @AndreaMiyahira @PCFnews to discuss a prognostic model for OS in patients with #mCRPC > https://t.co/unXPW6kM7K https://t.co/XLsqxqWh9V

  • Mashup Score: 1
    Unveiling the Role of Rb Gene in Prostate Cancer: BET Inhibitors and Immunotherapy - Akash Patnaik - 10 month(s) ago

    In this discussion with Andrea Miyahira, Akash Patnaik illuminates the role of the Rb gene in severe forms of prostate cancer and its intriguing interaction with the immune system. His team’s research uncovers that Rb loss is associated with lower immune infiltration and a higher presence of immunosuppressive genes. Patnaik’s team further observes an unexpected upregulation of the STING gene,…

    Source: UroToday
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Unveiling the role of the Rb gene in #ProstateCancer: BET inhibitors and immunotherapy. @AkashPatnaik7 @UCCancerCenter and @AndreaMiyahira @PCFnews examine Rb loss, lower immune infiltration, and a higher presence of immunosuppressive genes > https://t.co/n0VARrt4jG https://t.co/mnF3tqPfTp

Load More